CIB1 inhibitors (Reveris Therapeutics)

N/A

Report date: 2025/03/14 16:38:19
NME

Base Information

Drug NameCIB1 inhibitors (Reveris Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium and integrin-binding protein 1 inhibitors
TargetsCalcium and integrin-binding protein 1
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReveris Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesReveris Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A